No abstract

Marine and terrestrial organisms are an unlimited source of active secondary metabolites. They are characterized by high chemical diversity, biochemical specificity, and other molecular features that make them a valid starting point for lead generation in the drug discovery process. Considering the complex structural architecture and the high number of stereogenic centers, compared to the synthetic drugs, the elucidation of the 2D structure and the assessment of the precise 3D arrangements of natural products (NPs) provide essential insights into ligand‐target interaction which can drive a rational lead optimization process. In this regard, the combination of NMR spectroscopy with modern computational techniques represents one of the most effective approaches to achieve this task. The DFT/NMR integrated method, and its application, in combination with the accurate ROE‐distance analysis, have been employed as valid support, both to clarify the configuration and conformational profile of the active secondary metabolites and to shed more light on the molecular basis of their mechanism of action. Indeed, the comprehension at a molecular level of their interactions with specific targets involved in pathologies, like inflammation and cancer, represents a cornerstone for further investigations through computational tools like molecular docking and molecular dynamics. These high‐efficiency in silico techniques play a crucial part in the drug discovery process as well as in lead optimization procedures. Furthermore, this integrated approach provides the identification of novel chemical platforms disclosing new bioactive molecules with enhanced potency and selectivity.

New computational protocol applied to a repurposing campaign against SARS-CoV-2.

The object of the study was to estimate the long-lasting effects induced by ammonium glycyrrhizinate (AG) after a single administration in mice using animal models of pain and inflammation together with biochemical and docking studies. A single intraperitoneal injection of AG was able to produce anti-inflammatory effects in zymosan-induced paw edema and peritonitis. Moreover, in several animal models of pain, such as the writhing test, the formalin test, and hyperalgesia induced by zymosan, AG administered 24 h before the tests was able to induce a strong antinociceptive effect. Molecular docking studies revealed that AG possesses higher affinity for microsomal prostaglandin E synthase type-2 compared to type-1, whereas it seems to locate better in the binding pocket of cyclooxygenase (COX)-2 compared to COX-1. These results demonstrated that AG induced anti-inflammatory and antinociceptive effects until 24–48 h after a single administration thanks to its ability to bind the COX/mPGEs pathway. Taken together, all these findings highlight the potential use of AG for clinical treatment of pain and/or inflammatory-related diseases.